Variant report
Variant | esv3527153 |
---|---|
Chromosome Location | chr21:44969674-44974422 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:44934950..44937426-chr21:44968683..44970792,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RRP1B-5 | chr21:44971110-44971481 | NONHSAT082437 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL31P1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543817160 | chr21:44969700-44969701 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs183103964 | chr21:44969777-44969778 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs529030359 | chr21:44969786-44969787 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs73365870 | chr21:44969791-44969792 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs117437280 | chr21:44969811-44969812 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs187739799 | chr21:44969812-44969813 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs551725615 | chr21:44969850-44969851 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs191062487 | chr21:44969967-44969968 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs11701683 | chr21:44969970-44969971 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs537776831 | chr21:44969979-44969980 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs556075707 | chr21:44969995-44969996 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs115114750 | chr21:44970018-44970019 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs182571231 | chr21:44970043-44970044 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs147462309 | chr21:44970064-44970065 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs564406522 | chr21:44970099-44970100 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs572060327 | chr21:44970105-44970106 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs545502221 | chr21:44970122-44970123 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs138352669 | chr21:44970139-44970140 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs540937925 | chr21:44970148-44970149 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs115936483 | chr21:44970164-44970165 | Bivalent Enhancer Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs575615265 | chr21:44970234-44970235 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs56369437 | chr21:44970275-44970276 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs376794563 | chr21:44970285-44970286 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs11911293 | chr21:44970337-44970338 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs376999029 | chr21:44970368-44970369 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs188039823 | chr21:44970451-44970452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529090596 | chr21:44970577-44970578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532919216 | chr21:44970611-44970612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs8133167 | chr21:44970649-44970650 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs559615179 | chr21:44970676-44970677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368644579 | chr21:44970740-44970741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192662688 | chr21:44970742-44970743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs551571197 | chr21:44970951-44970952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183390673 | chr21:44971016-44971017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13052174 | chr21:44971067-44971068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7277854 | chr21:44971181-44971182 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs188071540 | chr21:44971350-44971351 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs370779176 | chr21:44971358-44971359 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs191949599 | chr21:44971364-44971365 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs551211653 | chr21:44971365-44971366 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs200861869 | chr21:44971462-44971463 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs547143861 | chr21:44971580-44971581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565652091 | chr21:44971693-44971694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539553946 | chr21:44971792-44971793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs143920109 | chr21:44971806-44971807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563024965 | chr21:44972074-44972075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566479282 | chr21:44972167-44972168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530555917 | chr21:44972209-44972210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139203901 | chr21:44972491-44972492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs8129384 | chr21:44972641-44972642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 21364760 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 23341502 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Prostate cancer | 18632612 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Cholangiocarcinoma | 16830362 | CNVD |
Down syndrome | 17334655 | CNVD |
Neuroticism | 17667963 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Autoimmune polyendocrine syndrome | 18200029 | CNVD |
Prostate cancer | 19363497 | CNVD |
Lung cancer | 17086460 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Multiple myeloma | 16616336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21509527 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 17142309 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:44967600-44976800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr21:44968000-44970400 | Enhancers | HSMMtube | muscle |
3 | chr21:44968600-44973400 | Weak transcription | Thymus | Thymus |
4 | chr21:44969000-44970200 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr21:44969000-44970200 | Enhancers | Fetal Lung | lung |
6 | chr21:44969000-44970400 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr21:44969000-44971400 | Enhancers | Placenta | Placenta |
8 | chr21:44969400-44970000 | Enhancers | Fetal Stomach | stomach |
9 | chr21:44969400-44970400 | Enhancers | HSMM | muscle |
10 | chr21:44969600-44969800 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr21:44969600-44970000 | Enhancers | Fetal Muscle Trunk | muscle |
12 | chr21:44970400-44973200 | Weak transcription | Fetal Muscle Leg | muscle |
13 | chr21:44970400-44982400 | Weak transcription | HSMMtube | muscle |
14 | chr21:44973000-44973600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr21:44973200-44973600 | Enhancers | Fetal Muscle Leg | muscle |
16 | chr21:44973400-44973600 | Enhancers | Thymus | Thymus |
17 | chr21:44973600-44973800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr21:44973800-44982400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |